P

Inventor

XU MEIZHONG

US40 patents
⚠️ This page may combine multiple inventors who share the name “XU MEIZHONG”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

INCYTE CORP

29 patents
US7767675B2Aug 3, 2010

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP85 citations99
US9533984B2Jan 3, 2017

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP42 citations98
US9533954B2Jan 3, 2017

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP42 citations98
US7776874B2Aug 17, 2010

Amido compounds and their use as pharmaceuticals

INCYTE CORP27 citations96
US7304081B2Dec 4, 2007

Amido compounds and their use as pharmaceuticals

INCYTE CORP42 citations96
US10947230B2Mar 16, 2021

Bicyclic heterocycles as FGFR inhibitors

INCYTE CORP26 citations94
US10813930B2Oct 27, 2020

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP27 citations94
US10793565B2Oct 6, 2020

Heterocyclic compounds as immunomodulators

INCYTE CORP27 citations94
US10213427B2Feb 26, 2019

Substituted imidazopyridazines and benzimidazoles as inhibitors of FGFR3

INCYTE CORP34 citations94
US9695168B2Jul 4, 2017

Substituted imidazo[1,5-α]pyridines and imidazo[1,5-α]pyrazines as LSD1 inhibitors

INCYTE CORP27 citations94
US9266892B2Feb 23, 2016

Fused pyrazoles as FGFR inhibitors

INCYTE CORP40 citations94
US7723349B2May 25, 2010

Aza spiro alkane derivatives as inhibitors of metalloproteases

INCYTE CORP21 citations93
US7683060B2Mar 23, 2010

Triazolotriazines as kinase inhibitors

INCYTE CORP25 citations92
US7687665B2Mar 30, 2010

2-methylprop anamides and their use as pharmaceuticals

INCYTE CORP24 citations90
US11566026B2Jan 31, 2023

Heterocyclic compounds as immunomodulators

INCYTE CORP16 citations86
US10640503B2May 5, 2020

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

INCYTE CORP7 citations84
US9957229B2May 1, 2018

Amido compounds and their use as pharmaceuticals

INCYTE CORP4 citations84
US9801877B2Oct 31, 2017

AZA spiro alkane derivatives as inhibitors of metalloproteases

INCYTE CORP7 citations84
US8039471B2Oct 18, 2011

Aza spiro alkane derivatives as inhibitors of metalloproteases

INCYTE CORP5 citations74
US7915408B2Mar 29, 2011

Triazolotriazines as kinase inhibitors

INCYTE CORP6 citations74
US10738052B2Aug 11, 2020

Imidazotriaines and imidazopyrimidines as kinase inhibitors

INCYTE CORP3 citations73
US10047086B2Aug 14, 2018

Imidazopyridines and imidazopyrazines as LSD1 inhibitors

INCYTE CORP2 citations73
US9403775B2Aug 2, 2016

AZA spiro alkane derivatives as inhibitors of metalloproteases

INCYTE CORP3 citations73
US11472791B2Oct 18, 2022

Pyrazolyl pyrimidinylamine compounds as CDK2 inhibitors

INCYTE CORP7 citations72
US12084449B2Sep 10, 2024

Imidazotriazines and imidazopyrimidines as kinase inhibitors

INCYTE CORP0 citations63
US11261191B2Mar 1, 2022

Imidazotriaines and imidazopyrimidines as kinase inhibitors

INCYTE CORP0 citations63
US12466828B2Nov 11, 2025

Bicyclic amines as CDK2 inhibitors

INCYTE CORP0 citations60
US10226459B2Mar 12, 2019

Aza spiro alkane derivatives as inhibitors of metalloproteases

INCYTE CORP0 citations52
US9670154B2Jun 6, 2017

Amido compounds and their use as pharmaceuticals

INCYTE CORP0 citations52

YAO WENQING

8 patents

ZHUO JINCONG

2 patents

INCYTE HOLDINGS CORP

1 patent